Skip to content

Alphatec Holdings ATEC Free cash flow margin

Free cash flow margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
Stryker logo
StrykerSYK
18.1%+2.7pp
Globus Medical logo
Globus MedicalGMED
19.7%-1.1pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
IAR
Integra LifeSciencesIART
3.8%-6.3pp
Enovis logo
EnovisENOV
-3.1%-1.1pp

Other financials

Income statement

See full
Revenue$192.1M+13.6%
Gross profit$136.5M+17.7%
Operating income-$22.6M+49.0%
Net income-$33.9M+34.7%
EPS (diluted)-$0.22+37.1%

Balance sheet

See full
Cash & equivalents$139.9M-8.7%
Total debt$603.1M+3.7%
Total equity-$5.3M+93.8%
Total assets$799.5M+1.8%

Cash flow

See full
Operating cash flow$1.3M+126%
CapEx$12.1M+21.7%
Free cash flow-$10.8M+27.9%

Valuation

See full
Market cap$1.34B+12.7%
Enterprise value$1.8B+11.7%
P/S1.7×-0.1×

Profitability

See full
Gross margin70.2%+1.2pp
Operating margin-7.7%-3.0pp
Net margin-15.9%-4.4pp

Returns & leverage

See full
Return on equity-812.1%
Debt / equity48×
Current ratio1.9×-0.9×

Where this comes from

Calculated from Alphatec Holdings’s reported figures.

Based on trailing twelve months.

The official record: Alphatec Holdings’s 10-Q, filed May 1, 2025, on SEC EDGAR. View the filing →

Ask your AI about Alphatec Holdings's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alphatec Holdings's free cash flow margin?
Alphatec Holdings (ATEC) reported free cash flow margin of -12.7% in Q1 2025.
How has Alphatec Holdings's free cash flow margin changed year-over-year?
Alphatec Holdings's free cash flow margin increased by 66.5% year-over-year, from -37.9% to -12.7%.
What is the long-term trend for Alphatec Holdings's free cash flow margin?
Over 4 years (2020 to 2024), Alphatec Holdings's free cash flow margin has grown at a -17.4% compound annual growth rate (CAGR), from -48% to -22.3%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.